Indian Journal of Animal Research

Indian Journal of Animal Research cover
Volume 60 · 2026/10/01

Besifloxacin/Mn Novel Metal Complex Ameliorates Hepatic Alterations in Male Rats via Modulating NRF-2 Antioxidant Hepatic Signalling Metabolism and NF-κB/ JNK and CHOP Oxidative Stress Pathway

Eman Hillal Althubaiti
59 Views

Submitted

2026/07/31

First Online

2026/10/01

doi

10.18805/IJAR.BF-2168

Cite article - Eman Hillal Althubaiti. (2026). Besifloxacin/Mn Novel Metal Complex Ameliorates Hepatic Alterations in Male Rats via Modulating NRF-2 Antioxidant Hepatic Signalling Metabolism and NF-κB/ JNK and CHOP Oxidative Stress Pathway. Indian Journal of Animal Research. 60: 102–112. doi: 10.18805/IJAR.BF-2168

Abstract

Background: Fluoroquinolone antibacterials are considered as the most beneficial antibacterial agents due to their high activity against various types of bacteria. Besifloxacin (Besi), is a novel fluoroquinolone antibacterial agent with a broad spectrum of activity. Besi demonstrates potent antibacterial activity in vitro against a wide range of pathogens; it has also shown high potency against a lot of infectious pathogens and other ocular and systemic infections. Less data are demonstrated in the literature on the tolerability of Besi novel metal drug complexes. The main objective of the current study is the treatment of hepatotoxicity and the oxidative stress damage via using novel metal drug complex in male rats.

Methods: Novel Manganese besifloxacin complex was synthesized. The ability of besifloxacin (Besi) to form chelates with divalent manganese was investigated. Confirmation the structures of the complex has been elucidated by CHN analysis, molar conductance, IR, UV-Vis spectral studies, magnetic moment, scanning electron microscopy (SEM), transmission electron microscopy (TEM) and X-ray powder diffraction (XRD). The data suggested that Besi form a 1:2 chelates with Mn (II) ion. The spectral data confirm that Besi act as bidentate via C=O and deprotonated COOH group. Eighteen male albino rats (6 Rats/group) were separated randomly into 3 treated groups. Control, Besi (100 mg/kg) and Besi/Mn (100 mg/kg) at the same dosages. At the end of the experiment, liver and blood samples were analyzed for biochemical, molecular and histological variations.

Result: Result revealing that Besi administration significantly elevated the levels of the liver enzymes as a result of Besi administration contrary to Besi/Mn administration. Histopathological examinations revealed inflammatory liver areas. Furthermore, induction of significant increases in NF-κB, JNK and CHOP as compared to the normal control group. Meanwhile, induction of a significant decline in NRF-2 level of Endoplasmic Reticulum oxidative damage, which was detected in the hepatocytes. In contrast to Besi/Mn novel complex treatment, significant hepatic amelioration was observed and a decline in hepatocellular congestion and oxidative stress genes after its administration. Besi/Mn complex was found to be with high antimicrobial potency.

References

  1. Albogami, B., Hamza, R.Z., Albaqami, N.M., Alshaya, D.S., Farsi, R.M., Alsolami K. et al . (2026). Ameliorative renal, anti oxidant and antibacterial activities of zinc-nitazoxanide complex with its spectroscopic characterization. Indian Journal of Animal Research . 60(8): 1408-1417. doi: 10.18805/IJAR.BF-2130 . AlZahrani, S.S., El-Megharbel, S.M., Al-Thubaiti,Thubaiti, E.H., Alghamdi, M.A., Hassoubah, S.A., Qattan, Y.A.S. et al . (2025). Chemical and spectroscopic characterization of novel dexamethasone/Zn complex as a potent antioxidant and antibacterial agent. Indian Journal of Animal Research . 59(8): 1329-1340. doi: 10.18805/IJAR.BF-1939 . Appelbaum, P.C. and Hunter, P.A. (2000). The fluoroquinolone antibacterials: Past, present and future perspectives. Int. J. Antimicrob. Agents . 16: 5-15. Besivance [package insert]. Rochester: Bausch and Lomb Inc (2009). Cambau, E., Matrat, S., Xiao-Su, P. et al . (2009). Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. J. Antimicrob Chemother . 63: 443-50. Cozzarelli, N.R. (1980). DNA gyrase and the supercoiling of DNA. Science . 207: 953-960. Cullity, B.D. (1978). Elements of X-ray Diffraction, 2 nd ed.; Addision- Wesley Publishing Company: Boston, MA, USA. Dean, A., Sullivan, K. and Soe, M. (2013). OpenEpi: Open-Source Epidemiologic Statistics for Public Health. Updated 2025/8/6. El-Megharbel, S.M., Albogami, B., Alaidaroos, B.A., Al-Gheffari, H.K., Albaqami, N.M. et al . (2025). Spectroscopic analysis of copper minocycline novel complex and evaluation of its potent antibacterial, antioxidant and anti-breast cancer (MCF-7) properties. Indian Journal of Animal Research . 59(7): 1120-1130. doi: 10.18805/IJAR.BF-1948 . El-Megharbel, S.M., Al-Zahrani,S.S., Al-Thubaiti, E.H., Hamza, R.Z., Albogami, B., Albaqami, J.J., Alsolami, K. et al . (2026). Spectroscopic characterization of Ca-ceftriaxonate salt synthesized and its free-radical scavenging and anti bacterial activities. Bulletin of the Chemical Society of Ethiopia . 40(3): 551-561. El-Megharbel, S.M., Qahl, S.H., Albogami, B. and Hamza, R.Z. (2024). Chemical and spectroscopic characterization of (Artemisinin/ Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats. Peer J. 12: e15638. Haas, W., Pillar, C., Hesje, C.K., Sanfilippo, C.M. and Morris, T.W. (2010). Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae. J. Antimicrob Chemother . 65: 1441-1447. Haas, W., Pillar, C.M., Torres, M., Morris, T.W. and Sahm, D.F. (2011). Monitoring antibiotic resistance in ocular microorganisms: Results from the ARMOR 2009 Surveillance Study. Am J Ophthalmol . 152: 567-574. Haas, W., Pillar, C.M., Zurenko, G.E. et al . (2009). Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria. Antimicrob Agents Chemother . 53: 3552-3560. Hamza, R.Z., El-Megharbel, S.M., Albogami, B. et al . (2026). Ameliorative effects of Crocin as a potent antioxidant with its spectral characterization against Cadmium chloride-induced hepatotoxicity. Sci Rep . 16: 27949 (2026). https://doi.org/ 10.1038/s41598-026-63088-9. Hollstein, V.U. (1974). Actinomycin. Chemistry and mechanism of action. Chem. Rev . 74(6): 625-652. Hooper, D.C. (1998). Clinical application of quinolones. Biochim. Biophys. Acta-Gene Struct. Express . 1400: 45-61. Hooper, D.C. (2000). Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis . 31: S24- S28. Hussy, P., Maass, G., Tmmler, B., Grosse, F. and Schomburg, U. (1986). Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase a primase complex, topoisomerases I and II and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother . 29: 1073-1108. Kadyrov, A.A., Neda, I., Kaukorat, T., Sonnenburg, R., Fischer, A., Jones, P.G. and Schmutzler, R. (1996). New phospholene and phosphepine derivatives irom λ3-phosphorus compounds and hexafluoroacetone or periluorinated α- diketones. Eur J Inorg Chem . 129: 725-732. Khamis, A., Abdalla, O., Hashem, M. and Abdelnaeim, N. (2022). Comparative effects of Phyllanthus niruri and Plantago major in Carbon Tetrachloride intoxicated rats. Adv Anim Vet Sci . 10: 1444-1450. Khodursky, A.B., Zechiedrich, E.L. and Cozzarelli, N.R. (1995). Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 92: 11801-11805. Lerman, L. (1961). Structural considerations in the interaction of DNA and acridines. J. Mol Biol . 3: 18-30. Livak, K.J. and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods . 25: 402-408. Lu, G.C., She, J.H., Jiang, H., Li, Z.Y. and Yuan, B.J. ( 2008). Sixty- day repeated dose toxicity of sinafloxacin in rat and dogs. Food Chem. Toxicol . 46: 575-580. Maeda, Y. and Okawara, R.J. (1967). Vibrational spectra of organo metallics: Theoretical and experimental data. Organometal. Chem . 10: 247. Malhotra, R., Ackerman, S., Gearinger, L.S., Morris, T.W. and Allaire, C. (2013). The safety of besifloxacin ophthalmic suspension 0.6% used three times daily for 7 days in the treatment of bacterial conjunctivitis. The safety of besifloxacin ophthalmic suspension 0.6 % used three times daily for 7 days in the treatment of bacterial conjunctivitis. Drugs in R and D. 13(4): 243-252 Mandell, L. and Tillotson, G. (2002). Safety of fluoroquinolones: An update. J. Infect. Dis . 13(1): 54-61. Maxwell, A. (1992). The molecular basis of quinolone action. J. Antimicrob. Chemother . 30: 409-414. Mitscher, L.A. (2005). Bacterial topoisomerase inhibitors: Quinolone and pyridone antibacterial agents. Chem. Rev . 105: 559- 592. Nakamoto, K. (1986). Infrared and Raman Spectra of Inorganic and Coordination Compounds, 4 th ed.; John Wiley: New York, NY, USA., 1986. Roy, B., Bose, A., Bhaumik, U., Das, A., Chatterjee, N., Ghosh, A., Darbar, S. et al . (2010). Convulsant activity and pharma cokinetic-pharmacodynamic modeling of the electroencephalogram effect of gemifloxacin in rats. J. Pharm. Sci . 99: 1535- 1547. Roy, B., Nandi, U., Das, A. and Pal, T.K. (2011). Acute and twenty- eight days repeated oral dose toxicity study of besifloxacin in Wistar albino rats. Environmental Toxicology and Pharmacology . 32(1): 82-101. Saha, S., Buttari, B., Panieri, E., Profumo, E. and Saso, L. (2020). An overview of Nrf2NRF2 signaling pathway and its role in inflammation. Molecules . 25(22): 5474. Sanders, M.E., Norcross, E.W., Moore, Q.C., Shafiee, A. and Marquart, M.E. (2009). Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea . 28(9): 1 055-1060. Sanfilippo, C.M., Hesje, C., Haas, W. and Morris, T.W. (2011). Topoisomerase mutations that are associated with high- level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin. Chemotherapy . 57: 363-371. Sonnenburg, R., Neda, I., Fischer, A., Jones, P.G. and Schmutzler, R. (1994). Compounds involving the 5, 6-Benzo-1, 3, 2- diazaphosphorinane-4-one ring system: synthesis of 2-chloro-, 2-N, N-dimethylamino- and 2-Bis-(2-chloroethyl) amino substituted derivatives with three- and four- coordinated phosphorus. Z Naturforsch . 49b: 788. Suvarna, S.K., Layton, C. and Bancroft, J.D. (2013). Bancroft’s Theory and Practice of Histological Techniques (7 th ed.). Churchill Livingstone Elsevier. Waring, M.J. (1964). Complex formation between ethidium bromide and nucleic acids. Biochem Biophys Acta . 87: 358. Wu, J.Y., Han, B., Yang, T., Zheng, L., Guo, Y.X., Li, J.Y., Guo, X.Y., Yin, H.H. and Xie, R.J. (2025). CHOP aggravates hepatocyte apoptosis upon endoplasmic reticulum stress by downregulating autophagy. Cell Stress and Chaperones . 30(3): 109- 118. Zhou, Y., Yuan, Y., Xie, Y. et al . (2026). Hepatic GAPDH prevents excessive fasting-induced steatosis via serine-dependent inhibition of diacylglycerol synthesis. Cell Death Differ . https://doi.org/10.1038/s41418-026-01706-9.
EDITORIAL BOARD

Guided by Experienced Academic Leadership

Distinguished scholars and subject experts committed to editorial excellence, scientific integrity and rigorous peer review.

View Full Board
Yashpal Singh Malik
Chief Editor

Yashpal Singh Malik

Deputy Director General (Agricultural Education)Indian Council of Agricultural Research, Headquarters, New Delhi , India

L.D. Singla
Associate chief editor

L.D. Singla

Professor and HeadAbhilashi University, Chachyot, Himachal Pradesh, India

Vilas G. Atkare
Editor

Vilas G. Atkare

DeanDr. Panjabrao Deshmukh Krishi Vidyapeeth, Akola, Krishi Nagar, Maharashtra, India

S. Maya
Editor

S. Maya

Associate Dean and Professor & HeadKerala Veterinary and Animal Sciences University, Mannuthy, Thrissur, Kerala, India